- Lobbying
- Lobbying by Consumer Healthcare Products Association
Lobbying Relationship
Bills mentioned
H.R.394: Restoring Access to Medication Act of 2017
Sponsor: Lynn Jenkins (R-Kan.)
S.85: Restoring Access to Medication Act of 2017
Sponsor: Pat Roberts (R-Kan.)
S.CON.RES.3: A concurrent resolution setting forth the congressional budget for the...
Sponsor: Michael B. Enzi (R-Wyo.)
H.R.1628: American Health Care Act of 2017
Sponsor: Diane Black (R-Tenn.)
H.R.1271: DXM Abuse Prevention Act of 2017
Sponsor: Bill Johnson (R-Ohio)
H.R.2430: FDA Reauthorization Act of 2017
Sponsor: Greg Walden (R-Ore.)
H.R.1270: Restoring Access to Medication and Improving Health Savings Act of 2016
Sponsor: Lynn Jenkins (R-Kan.)
S.709: Restoring Access to Medication Act of 2015
Sponsor: Pat Roberts (R-Kan.)
H.R.3250: DXM Abuse Prevention Act of 2015
Sponsor: Bill Johnson (R-Ohio)
S.2994: DXM Abuse Prevention Act of 2016
Sponsor: Bob Casey (D-Pa.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.1321: Microbead-Free Waters Act of 2015
Sponsor: Frank Pallone (D-N.J.)
H.R.2835: Restoring Access to Medication Act of 2013
Sponsor: Lynn Jenkins (R-Kan.)
S.1647: Restoring Access to Medication Act
Sponsor: Pat Roberts (R-Kan.)
S.644: PACT Act
Sponsor: Bob Casey (D-Pa.)
H.R.3969: PACT Act
Sponsor: Bill Johnson (R-Ohio)
H.R.4502: Stop Meth Labs and Enhance Patient Access Act of 2014
Sponsor: Blaine Luetkemeyer (R-Mo.)
H.R.2725: Food and Drug Administration Safety Over Sequestration Act of 2013
Sponsor: Leonard Lance (R-N.J.)
S.1413: FDA User Fee Protection Act
Sponsor: Mark Pryor (D-Ark.)
H.R.4618: To amend the Internal Revenue Code of 1986 to provide for a temporary...
Sponsor: Lynn Jenkins (R-Kan.)
H.R.5333: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Sponsor: Robert E. Latta (R-Ohio)
S.2315: Over-the-Counter Drug Safety, Innovation, and Reform Act
Sponsor: Johnny Isakson (R-Ga.)
H.R.6199: Restoring Access to Medication and Modernizing Health Savings Accounts...
Sponsor: Lynn Jenkins (R-Kan.)
H.R.1922: Restoring Access to Medication Act of 2019
Sponsor: Ron Kind (D-Wis.)
H.R.863: DXM Abuse Prevention Act of 2019
Sponsor: Doris Matsui (D-Calif.)
H.R.269: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.3443: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Sponsor: Diana DeGette (D-Colo.)
H.R.1865: Further Consolidated Appropriations Act, 2020
Sponsor: Bill Pascrell Jr. (D-N.J.)
S.2740: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Sponsor: Johnny Isakson (R-Ga.)
H.R.748: CARES Act
Sponsor: Joe Courtney (D-Conn.)
S.1089: Restoring Access to Medication Act of 2019
Sponsor: Pat Roberts (R-Kan.)
H.R.5279: Cosmetic Safety Enhancement Act of 2019
Sponsor: Frank Pallone (D-N.J.)
S.1260: United States Innovation and Competition Act of 2021
Sponsor: Charles E. Schumer (D-N.Y.)
H.R.4405: Small Business FDA User Fee Adjustment Act of 2021
Sponsor: Greg Steube (R-Fla.)
H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act...
Sponsor: David Cicilline (D-R.I.)
S.1435: Affordable Prescriptions for Patients Act of 2021
Sponsor: John Cornyn (R-Texas)
H.R.2617: Consolidated Appropriations Act, 2023
Sponsor: Gerald E. Connolly (D-Va.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Lisa Kountoupes | Deputy Asst. to the President & House Liaison Special Asst. to the President for Legis. Affairs Asst. Director for Legislative Affairs at OMB Special Asst. to Undersecretary, Dept. of Energy Policy Adv. to Chmn.,Energy&Commerce Comm. Policy Adv. to Chmn.,Energy & Commerce Comm. |
Julie Hershey Carr | LA, LD & Sr. Policy Advisor, Rep. Joe Pitts, R-PA LA,LD&Sr.Policy Advisor, Rep. Joe Pitts, R-PA LA,LD & Sr. Policy Advisor, Rep. Joe Pitts, R-PA LA,LD&Sr. Policy Advisor, Rep. Joe Pitts, R-PA |
Lori Denham | CoS, LD, LA, Sr. Policy Advisor, Communications Director, Staff Assistant, Rep. Cal Dooley, D-CA Legislative Director, Rep. Darlene Hooley, D-OR CoS,LD,LA,Sr.Policy Advisor, Communications Director, Staff Assistant, Rep. Cal Dooley, D-CA CoS,LD,LA,Sr. Policy Advisor, Communications |
Shawn Whitman | CoS - Senator John Barrasso CoS, LD, LA, LC & Press Asst - Sen. Craig Thomas Staff Assistant - Senator Alan Simpson |
Mary "Randi" Reid | LA,Sr.LA&Projects Dir.,LD-Sen.Michael Enzi Legislative Dir., Rep. Michael Burgess, R-TX *Mary is abiding by the one year ban on lobbying the Senate |
Mary Reid | LA,Sr. LA&Projects Dir.,LD-Sen. Michael Enzi Legislative Director - Cong. Michael Burgess * Mary is abiding by the one year ban on lobbying the Senate lobbying the Senate. LA,Sr.LA&Projects Dir.,LD-Sen.Michael Enzi *Mary is abiding by the one year ban on |
Adam Hechavarria | Legislative Director-Sen.Todd Young,R-IN;Legislative Director-Sen.Kelly Ayotte,R-NH;Budget Analyst-Senate Budget Committee;Legislative Asst,Legislative Aide,Legislative Correspondent,Staff Asst, Correspondence Asst-Sen.John E. Sununu,R-NH Legislative Director - Sen.Todd Young,R-IN;Legislative Director-Sen. Kelly Ayotte, R-NH; Budget Analyst-Senate Budget Committee; Legislative Asst,Legislative Aide, Legislative Correspondent, Staff Asst,Correspondence Asst-Sen. John E. Sununu,R-NH |
Mary Dee Beal | Policy Analyst,Senate Republican Policy Committee;Acting Chief of Staff to the Deputy Secretary,USDA;Senior Advisor to the Secretary,USDA;Legislative Director,Cong. Drew Ferguson,R-GA; Legis. Director, Legis. Assistant, Scheduler Cong. Austin Scott,R |
Leslie Zelenko | Deputy Assistant Secretary for Legislation, Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tammy Baldwin, D-W |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Treasury - Dept of
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Treasury - Dept of
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
White House Office
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Health & Human Services - Dept of (HHS)
White House Office
U.S. House of Representatives
Food & Drug Administration (FDA)
U.S. House of Representatives
U.S. Senate
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Office of Management & Budget (OMB)
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate